Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain

Blood

Volumn 98, Issue 6, 2001, Pages 1645-1653

  Zhang, Zhushan ^a   Weed, Scott A ^a   Gallagher, Patrick G ^a   Morrow, Jon S ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FODRIN; SPECTRIN;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; CYTOSKELETON; DISEASE SEVERITY; DROSOPHILA; ERYTHROCYTE; GENE MUTATION; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; STRUCTURE ANALYSIS;

DROSOPHILA;

EID: 0035885947     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1645     Document Type: Article

References (56)

1. De Matteis MA, Morrow JS. Spectrin tethers and mesh in the biosynthetic pathway. J Cell Sci. 2000;113:2331-2343.
2. Morrow JS, Rimm DL, Kennedy SP, Cianci CD, Sinard JH, Weed SA. Of membrane stability and mosaics: the spectrin cytoskeleton. In: Hoffman J, Jamieson J, eds. Handbook of Physiology. London, UK: Oxford; 1997:485-540.
3. Tse WT, Lux SE. Red blood cell membrane disorders. Br J Haematol. 1999;104:2-13.
4. Corbett JD, Agre P, Palek J, Golan DE. Differential control of band 3 lateral and rotational mobility in intact red cells. J Clin Invest. 1994;94:683-688.
5. Mohandas N, Evans E. Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. Annu Rev Biophys Biomol Struct. 1994;23:787-818.
6. Delaunay J, Dhermy D. Mutations involving the spectrin heterodimer contact site: clinical expression and alterations in specific function. Semin Hematol. 1993;30:21-33.
7. Gallagher PG, Jarolim P. Red cell membrane disorders. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. 3rd ed. New York, NY: Churchill Livingstone; 2000:576-610.
8. Winkelmann JC, Forget BG. Erythroid and nonerythroid spectrins. Blood. 1993;81:3173-3185.
9. Sahr KE, Laurila P, Kotula L, et al. The complete cDNA and polypeptide sequences of human erythroid α-spectrin. J Biol Chem. 1990;265:4434-4443.
10. Winkelmann JC, Chang JG, Tse WT, Scarpa AL, Marchesi VT, Forget BG. Full-length sequence of the cDNA for human erythroid beta-spectrin. J Biol Chem. 1990;265:11827-11832.
11. Morrow JS, Speicher DW, Knowles WJ, Hsu CJ, Marchesi VT. Identification of functional domains of human erythrocyte spectrin. Proc Nat Acad Sci U S A. 1980;77:6592-6596.
12. Morrow JS, Marchesi VT. Self-assembly of spectrin oligomers in vitro: a basis for a dynamic cytoskeleton. J Cell Biol. 1981;88:463-468.
13. Knowles WJ, Morrow JS, Speicher DW, et al. Spectrin from patients with hereditary pyropoikilocytosis have self-association defects and an abnormal tryptic digestion map. ICN/UCLA Symposium on Differentiation and Function of Hematopoietic Cell Surfaces, Keystone, CO, February, 1981.
14. Knowles WJ, Morrow JS, Speicher DW, et al. Molecular and functional changes in spectrin from patients with hereditary pyropoikilocytosis. J Clin Invest. 1983;71:1867-1877.
15. Lux SE, Palek J. Disorders of the red cell membrane. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Philadelphia, PA: Lippincott; 1995:1701-1816.
16. Speicher DW, Marchesi VT. Erythrocyte spectrin is comprised of many homologous triple helical segments. Nature (London). 1984;311:177-180.
17. Yan Y, Winograd E, Viel A, Cronin T, Harrison SC, Branton D. Crystal structure of the repetitive segments of spectrin. Science. 1993;262:2027-2030.
18. Pascual J, Pfuhl M, Rivas G, Pastore A, Saraste M. The spectrin repeat folds into a three-helix bundle in solution. FEBS Lett. 1996;383:201-207.
19. Pascual J, Pfuhl M, Walther D, Saraste M, Nilges M. Solution structure of the spectrin repeat: a left-handed antiparallel triple-helical coiled-coll. J Mol Biol. 1997;273:740-751.
20. Ralston GB, Dunbar JC. Salt and temperature-dependent conformation changes in spectrin from human erythrocyte membranes. Biochim Biophys Acta. 1979;579:20-30.
21. Calvert R, Ungewickell E, Gratzer W. A conformational study of human spectrin. Eur J Biochem. 1980;107:363-367.
22. LaBrake CC, Wang L, Keiderling TA, Fung LW. Fourier transform infrared spectroscopic studies of the secondary structure of spectrin under different ionic strengths. Biochemistry. 1993;32: 10296-10302.
23. Grum VL, Li D, MacDonald RI, Mondragon A. Structures of two repeats of spectrin suggest models of flexibility. Cell. 1999;98:523-535.
24. Tse WT, Lecomte MC, Costa FF, et al. Point mutation in the beta-spectrin gene associated with alpha I/74 hereditary elliptocytosis: implications for the mechanism of spectrin dimer self-association. J Clin Invest. 1990;86:909-916.
25. Nicolas G, Pedroni S, Fournier C, et al. Spectrin self-association site: characterization and study of beta-spectrin mutations associated with hereditary elliptocytosis. Biochem J. 1998;332:81-89.
26. Speicher DW, DeSilva TM, Speicher KD, Ursitti JA, Hembach P, Weglarz L. Location of the human red cell spectrin tetramer binding site and detection of a related "closed" hairpin loop dimer using proteolytic footprinting. J Biol Chem. 1993;268:4227-4235.
27. Kennedy SP, Weed SA, Forget BG, Morrow JS. A partial structural repeat forms the heterodimer self-association site of all β-spectrins. J Biol Chem. 1994;269:11400-11408.
28. Cherry L, Menhart N, Fung LW. Interactions of the alpha-spectrin N-terminal region with beta-spectrin: implications for the spectrin tetramerization reaction. J Biol Chem. 1999;274:2077-2084.
29. Lecomte MC, Nicolas G, Dhermy D, Pinder JC, Gratzer WB. Properties of normal and mutant polypeptide fragments from the dimer self-association sites of human red cell spectrin. Eur Biophys J. 1999;28:208-215.
30. Zhang Z, Weed SA, Morrow JS. Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain [abstract]. FASEB J. 1999;13:A1394.
31. Brünger AT. X-Plor: A system for x-ray crystallography and NMR (ed X-plor pre-release version 3.851, available via the Internet [1996]). New Haven, CT: Yale University Press; 1992.
32. Biosym Technologies. Insight II User guide (ed 2.3.0), 1993.
33. Veriet L. Computer experiments on classical fluid, I: thermodynamical properties of Lennard-Jones molecules. Physical Rev. 1967;159:98-103.
34. Powell MJD. Restart procedures for the conjugate gradient method. Mathematical Programming. 1977;12:141-254.
35. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984;12:387-395.
36. Stabach PR, Cianci CD, Glantz SB, Zhang Z, Morrow JS. Site-directed mutagenesis of αII spectrin (fodrin) reveals determinants of its μ-calpain susceptibility. Biochemistry. 1997;36:57-65.
37. Gallagher PG, Weed SA, Tse WT, et al. Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene [see comments]. J Clin Invest. 1995;95:1174-1182.
38. Garbarz M, Lecomte MC, Feo C, et al. Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain. Blood. 1990;75:1691-1698.
39. Wilmotte R, Marechal J, Morle L, et al. Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46. J Clin Invest. 1993;91:2091-2096.
40. Speicher DW, Morrow JS, Knowles WJ, Marchesi VT. Identification of proteolytically resistant domains of human erythrocyte spectrin. Proc Natl Acad Sci U S A. 1980;77:5673-5677.
41. Gallagher PG, Forget BG. Hematologically important mutations: spectrin variants in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells Mol Dis. 1996;22:254-258.
42. Gallagher PG, Petruzzi MJ, Weed SA, Zhang Z, Marchesi SL, Mohandas N, Morrow JS, Forget BG. Mutation of a highly conserved residue of betal spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest. 1997;99:267-277.
43. Sahr KE, Coetzer TL, Moy LS, et al. Spectin Cagliari: an Ala→Gly substitution in helix 1 of beta spectrin repeat 17 that severely disrupts the structure and self-association of the erythrocyte spectrin heterodimer. J Biol Chem. 1993;268: 22656-22662.
44. Parquet N, Devaux I, Boulanger L, et al. Identification of three novel spectrin alpha I/74 mutations in hereditary elliptocytosis: further support for a triple-stranded folding unit model of the spectrin heterodimer contact site. Blood. 1994;84:303-308.
45. Glele-Kakai C, Garbarz M, Lecomte MC, et al. Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrin polymorphisms in Benin. Br J Haematol. 1996;95: 57-66.
46. Qualtieri A, Pasqua A, Bisconte MG, Le Pera M, Brancati C. Spectrin Cosenza: a novel beta chain variant associated with Sp alpha1/74 hereditary elliptocytosis. Br J Haematol. 1997;97:273-278.
47. Baklouti F, Marechal J, Morle L, et al. Occurrence of the alpha I 22 Arg→His (CGT→CAT) spectrin mutation in Tunisia: potential association with severe elliptocytosis. Br J Haematol. 1991;78:108-113.
48. Coetzer TL, Sahr K, Prchal J, et al. Four different mutations in codon 28 alpha spectrin are associated with structurally and functionally abnormal spectrin alpha1/74 in hereditary elliptocytosis. J Clin Invest. 1991;88:743-749.
49. Randon J, Boulanger L, Marechal J, et al. A variant of spectrin low-expression allele alpha LELY carrying a hereditary elliptocytosis mutation in codon 28. Br J Haematol. 1994;88:534-540.
50. Floyd PB, Gallagher PG, Valentino LA, Davis M, Marchesi SL, Forget BG. Heterogeneity of the molecular basis of hereditary pyropoikilocytosis and hereditary elliptocytosis associated with increased levels of the spectrin alpha1/74-kilodalton tryptic peptide. Blood. 1991;78:1365-1372.
51. Lorenzo F, Miraglia del Giudice E, Alloisio N, et al. Severe poikilocytosis associated with a de novo alpha 28 Arg→Cys mutation in spectrin. Br J Haematol. 1993;83:152-157.
52. Perrotta S, Miraglia del Giudice E, Alloisio N, et al. Mild elliptocytosis associated with the alpha 34 Arg→Trp mutation in Genova (alpha I/74). Blood. 1994;83:3346-3349.
53. Morle L, Morle F, Roux AF, et al. Spectrin Tunis (Sp alpha I/78), an elliptocytogenic variant, is due to the CGG→TGG condon change (Arg→Trp) at position 35 of the alpha I domain. Blood. 1989;74: 828-832.
54. Lecomte MC, Garbarz M, Grandchamp B, et al. Sp alpha I/78: a mutation of the alpha I spectrin domain in a white kindred with HE and HPP phenotypes. Blood. 1989;74:1126-1133.
55. Perrotta S, Iolascon A, De Angelis F, et al. Spectrin Anastasia (alpha I/78): a new spectrin variant (alpha 45 Arg→Thr) with moderate elliptocytogenic potential. Br J Haematol. 1995;89:933-936.
56. Morle L, Roux AF, Alloisio N, et al. Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain: Spectrin Culoz (GGT→GTT; alpha I 40 Gly→Val) and spectrin Lyon (CTT→TTT, alpha I 43 Leu→Phe). J Clin Invest. 1990;86:548-554.